Target intelligence / Profile preview

LLGL scribble cell polarity complex component 1 (LLGL1)

Target
LLGL1
Molecular classification
Other, Cell polarity protein, Tumor suppressor protein
01

Overview

LLGL scribble cell polarity complex component 1 (LLGL1, commonly known as Lethal giant larvae homolog 1 or Lgl1) is a highly conserved protein that functions as part of the Scribble polarity complex, together with Scribble (Scrib) and Discs large (Dlg)[1][2][3][5]. This complex is essential for the establishment and maintenance of cell polarity, cell adhesion, and directed cell migration in a broad range of tissues and organisms, from fruit flies to mammals[1][3][5]. LLGL1 acts as a scaffold or adaptor protein, interacting with other polarity proteins such as Scrib and Dlg to regulate the assembly and stability of multi-protein complexes crucial for apicobasal polarity and tissue architecture[1][3]. Loss or decreased expression of LLGL1 has been associated with loss of cell polarity, increased cell migration, tissue disorganization, and neoplastic transformation (acting as a tumor suppressor)[1][3][5]. In carcinomas, the Scrib-Lgl-Dlg module is frequently disrupted, contributing to the development and progression of cancer[1][3][5]. LLGL1 also plays a role in the regulation of cell junctions, including both adherens and tight junctions, which impact tissue barrier functions[2][3]. **LLGL1 is not a classical therapeutic target** such as a receptor, enzyme, or transporter. No drugs are currently known to directly interact with it. However, its crucial role in cancer biology and tissue homeostasis makes it an important subject of research for biomarker discovery and understanding the molecular mechanisms underlying tumorigenesis[1][3][5].

Other names
Lethal giant larvae homolog 1Lgl1Lethal giant larvae protein homolog 1Hugl-1
02

Biological functions

Cell polarity regulationCell migrationCell adhesionCell proliferation controlTissue morphogenesisMaintenance of epithelial barrier functions
03

Disease associations

Cancer (notably epithelial cancers and tumor suppression)Neurodevelopmental diseasesOther (e.g., tissue disorganization disorders)
04

Biomarkers

Decreased expression of LLGL1 observed in several tumor cell lines (potential diagnostic/prognostic biomarker for some cancers)

Beyond the preview

Go deeper on LLGL scribble cell polarity complex component 1 (LLGL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LLGL scribble cell polarity complex component 1 (LLGL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call